All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Search results for “”
Show results per page.
Showing 276–300 of 1301 results.
Chapter 8: Immunomodulatory treatments and malignant disease
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease Patients on chemotherapy at home
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/patients-on-chemotherapy-at-home The Cancer Drugs Fund (CDF)
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/the-cancer-drugs-fund-cdf General information and contact details
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/general-information-and-contact-details 8.1 Selective internal radiation therapy (SIRT)
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-1-selective-internal-radiation-therapy-sirt 8.2.1 Immunosuppressive agents
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-2-drugs-affecting-the-immune-response/8-2-1-immunosuppressive-agents 8.2.2 Immunostimulants
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-2-drugs-affecting-the-immune-response/8-2-2-immunostimulants 8.3.1 Oestrogens
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-3-sex-hormones-and-hormone-antagonists/8-3-1-oestrogens 8.3.2 Progestogens
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-3-sex-hormones-and-hormone-antagonists/8-3-2-progestogens 8.3.4 Hormone antagonists
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-3-sex-hormones-and-hormone-antagonists/8-3-4-hormone-antagonists 8.4.1 Alkylating agents
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-1-alkylating-drugs 8.4.2 Anthracyclines
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-2-anthracyclines 8.4.3 Antifolates
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-3-antifolates 8.4.4 Antimetabolites
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-4-antimetabolites 8.4.5 Cytotoxic antibiotics
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-5-cytotoxic-antibiotics 8.4.6 Drugs for cytotoxic-induced side effects
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-6-cytotoxic-side-effects 8.4.7 Nucleoside analogues
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-7-nucleoside-analogues 8.4.8 Platinum compounds
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-8-platinum-compounds 8.4.9 Podophyllotoxins
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-9-podophyllotoxins 8.4.10 Taxanes
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-10-taxanes 8.4.11 Topoisomerase I inhibitors
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-11-topoisomerase-i-inhibitors 8.4.12 Vinca alkaloids
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-12-vinca-alkaloids 8.4.13 Other cytotoxic antineoplastics
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-13-other-cytotoxic-antineoplastics 8.5.1 Epidermal growth factor receptor (EGFR) inhibitors
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-5-targeted-antineoplastics/8-5-1-epidermal-growth-factor-receptor-egfr-inhibitors 8.5.2 Human epidermal growth factor receptor (HER2) inhibitors
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-5-targeted-antineoplastics/8-5-2-human-epidermal-growth-factor-receptor-her2-inhibitors
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease Patients on chemotherapy at home
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/patients-on-chemotherapy-at-home The Cancer Drugs Fund (CDF)
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/the-cancer-drugs-fund-cdf General information and contact details
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/general-information-and-contact-details 8.1 Selective internal radiation therapy (SIRT)
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-1-selective-internal-radiation-therapy-sirt 8.2.1 Immunosuppressive agents
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-2-drugs-affecting-the-immune-response/8-2-1-immunosuppressive-agents 8.2.2 Immunostimulants
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-2-drugs-affecting-the-immune-response/8-2-2-immunostimulants 8.3.1 Oestrogens
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-3-sex-hormones-and-hormone-antagonists/8-3-1-oestrogens 8.3.2 Progestogens
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-3-sex-hormones-and-hormone-antagonists/8-3-2-progestogens 8.3.4 Hormone antagonists
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-3-sex-hormones-and-hormone-antagonists/8-3-4-hormone-antagonists 8.4.1 Alkylating agents
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-1-alkylating-drugs 8.4.2 Anthracyclines
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-2-anthracyclines 8.4.3 Antifolates
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-3-antifolates 8.4.4 Antimetabolites
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-4-antimetabolites 8.4.5 Cytotoxic antibiotics
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-5-cytotoxic-antibiotics 8.4.6 Drugs for cytotoxic-induced side effects
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-6-cytotoxic-side-effects 8.4.7 Nucleoside analogues
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-7-nucleoside-analogues 8.4.8 Platinum compounds
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-8-platinum-compounds 8.4.9 Podophyllotoxins
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-9-podophyllotoxins 8.4.10 Taxanes
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-10-taxanes 8.4.11 Topoisomerase I inhibitors
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-11-topoisomerase-i-inhibitors 8.4.12 Vinca alkaloids
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-12-vinca-alkaloids 8.4.13 Other cytotoxic antineoplastics
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-4-cytotoxic-antineoplastics/8-4-13-other-cytotoxic-antineoplastics 8.5.1 Epidermal growth factor receptor (EGFR) inhibitors
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-5-targeted-antineoplastics/8-5-1-epidermal-growth-factor-receptor-egfr-inhibitors 8.5.2 Human epidermal growth factor receptor (HER2) inhibitors
https://southwest.devonformularyguidance.nhs.uk/formulary/chapters/8-immunomodulatory-treatments-and-malignant-disease/8-5-targeted-antineoplastics/8-5-2-human-epidermal-growth-factor-receptor-her2-inhibitors
